Death (between ages 1 and 6 years) · public health programmes to regularly treat all children aged 16 years or less
Multiple doses of deworming drugs showed no clear difference in mortality (between ages 1 and 6 years) compared with placebo (low certainty).
1 finding from 1 review
Convalescent faecal carriage · children under 18 years of age with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cumulative cases of typhoid fever at 2 years · adults and children of 2 years of age and older
Vi‐rEPA vaccine (2 doses) probably leads to lower cumulative cases of typhoid fever at 2 years compared with control (moderate certainty).
2 findings from 1 review
Cumulative cases of typhoid fever at 2.5 to 3 years · adults and children aged 5 years of age and older
Ty21a vaccine (three doses) probably leads to lower cumulative cases of typhoid fever at 2.5 to 3 years compared with control (moderate certainty).
1 finding from 1 review
Cumulative cases of typhoid fever at 2.5 to 3 years · adults and children of 2 years of age and older
Vi polysaccharide vaccine (1 dose) may leads to lower cumulative cases of typhoid fever at 2.5 to 3 years compared with control (low certainty).
1 finding from 1 review
Intervention not reported
Child death by two years of age · HIV‐positive women during pregnancy and immediate postpartum period
The intervention showed no clear difference in child death by two years of age (low certainty).
1 finding from 1 review
All‐cause mortality · children under 5 years of age
1 finding from 1 review
Cause‐specific mortality · children under 5 years of age
1 finding from 1 review
Incidence rate radiologically confirmed first or only episode of pneumonia · children under 5 years of age
1 finding from 1 review
Hospital admissions · children under 5 years of age
1 finding from 1 review
TB cases · children under 5 years of age
1 finding from 1 review
Diarrhoea · children under 5 years of age
1 finding from 1 review
Malaria cases · children under 5 years of age
1 finding from 1 review
Febrile illness · children under 5 years of age
1 finding from 1 review
Mean serum vitamin D concentrations · children under 5 years of age
1 finding from 1 review
Long‐term tuberculosis prevalence · Individuals of all ages
It is very uncertain whether health promotion activities changes long‐term tuberculosis prevalence (assessed at 4 years) compared with no intervention (very low certainty).
1 finding from 1 review
RR 1.31
405788 participants
Very low
Relapse · children under 18 years of age with enteric fever
It is very uncertain whether ceftriaxone changes relapse compared with azithromycin (very low certainty).
1 finding from 1 review
Time to defervescence · children under 18 years of age with enteric fever
Ceftriaxone showed no clear difference in time to defervescence compared with azithromycin (low certainty).
1 finding from 1 review
Length of hospital stay · children under 18 years of age with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · children under 18 years of age with enteric fever
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found